{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:02:22Z","timestamp":1780063342646,"version":"3.54.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"DOI":"10.7759\/cureus.91427","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:22:36Z","timestamp":1756747356000},"source":"Crossref","is-referenced-by-count":2,"title":["Beyond Mean Absolute Relative Difference (MARD): Rethinking Continuous Glucose Monitoring (CGM) Evaluation for Real-World Diabetes Care"],"prefix":"10.7759","author":[{"given":"Matteo","family":"Acanfora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Presciuttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"R\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Acanfora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1932296819855670","article-title":"Benefits and limitations of MARD as a performance parameter for continuous glucose monitoring in the interstitial space","volume":"14","author":"Heinemann L","year":"2020","unstructured":"Heinemann L, Schoemaker M, Schmelzeisen-Redecker G, et al..  Benefits and limitations of MARD as a performance parameter for continuous glucose monitoring in the interstitial space. J Diabetes Sci Technol. 2020, 14:135-50. 10.1177\/1932296819855670","journal-title":"J Diabetes Sci Technol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221085273","article-title":"A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","volume":"17","author":"Klonoff DC","year":"2023","unstructured":"Klonoff DC, Wang J, Rodbard D, et al.. A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J Diabetes Sci Technol. 2023, 17:1226-42. 10.1177\/19322968221085273","journal-title":"J Diabetes Sci Technol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814539589","article-title":"The surveillance error grid","volume":"8","author":"Klonoff DC","year":"2014","unstructured":"Klonoff DC, Lias C, Vigersky R, et al.. The surveillance error grid. J Diabetes Sci Technol. 2014, 8:658-72. 10.1177\/1932296814539589","journal-title":"J Diabetes Sci Technol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700404","article-title":"Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment","volume":"7","author":"Obermaier K","year":"2013","unstructured":"Obermaier K, Schmelzeisen-Redeker G, Schoemaker M, Kl\u00f6tzer HM, Kirchsteiger H, Eikmeier H, del Re L. Performance evaluations of continuous glucose monitoring systems: precision absolute relative deviation is part of the assessment. J Diabetes Sci Technol. 2013, 7:824-32. 10.1177\/193229681300700404","journal-title":"J Diabetes Sci Technol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck RW","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown AS, Close KL. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019, 42:400-5. 10.2337\/dc18-1444","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0143","article-title":"Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator","volume":"20","author":"Shah VN","year":"2018","unstructured":"Shah VN, Laffel LM, Wadwa RP, Garg SK. Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator. Diabetes Technol Ther. 2018, 20:428-33. 10.1089\/dia.2018.0143","journal-title":"Diabetes Technol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S007","article-title":"7. Diabetes Technology: Standards of Care in Diabetes-2025","volume":"48","year":"2025","unstructured":"7. Diabetes Technology. Standards of Care in Diabetes-2025. Diabetes Care. 2025, 48:S146-66. 10.2337\/dc25-S007","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt RI","year":"2021","unstructured":"Holt RI, DeVries JH, Hess-Fischl A, et al.. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021, 64:2609-52. 10.1007\/s00125-021-05568-3","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino T","year":"2023","unstructured":"Battelino T, Alexander CM, Amiel SA, et al.. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023, 11:42-57. 10.1016\/S2213-8587(22)00319-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig DS","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, et al.. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017, 390:2347-59. 10.1016\/S0140-6736(17)32400-5","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406761-beyond-mean-absolute-relative-difference-mard-rethinking-continuous-glucose-monitoring-cgm-evaluation-for-real-world-diabetes-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:22:37Z","timestamp":1756747357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406761-beyond-mean-absolute-relative-difference-mard-rethinking-continuous-glucose-monitoring-cgm-evaluation-for-real-world-diabetes-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91427","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}